Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
Based on 90 significantly associated SNPs, Bingrui Gao et al performed bidirectional MR analyses of vitamin D and PCOS.
Source: 3.5.4. Effects of other physiological traits. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Systematic review.
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Meta-analysis not reported · Blinding not applicable to this review · Research setting awaiting verification
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
This work is a systematic review and secondary analysis built entirely on previously published GWAS summary statistics; it did not involve the collection of new data from human participants or animals, nor any personally identifiable information.
Source: Methods.
For evidence synthesis, we performed a narrative synthesis following the principles of the Synthesis Without Meta-analysis (SWiM) reporting guideline.
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Mapping the causal landscape of polycystic ovary syndrome
Systematic review · Medicine · 2026
Original publication title
Mapping the causal landscape of polycystic ovary syndrome
Copyright © 2026 the Author(s). Published by Wolters Kluwer Health, LLC.
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
What does the authors’ abstract report?
Mendelian randomization (MR) studies have increasingly investigated potential predicted antecedents and consequences of polycystic ovary syndrome (PCOS), yet published evidence remains scattered across diverse exposures, outcomes, and analytical frameworks. This study aimed to systematically organize published PCOS-related MR evidence and develop an interactive platform to support evidence retrieval, comparison, and interpretation. We searched PubMed, Web of Science, Embase, and the Cochrane Library from inception to June 1, 2026. Original MR Studies were eligible if PCOS was either the exposure or the outcome, with extractable effect estimates.
Each causal pathway was extracted separately for direction, definitions, effect estimates, primary MR method, Genome-Wide Association Study sources, ancestry, sample size, PCOS phenotype, sensitivity analyses, and sample overlap. Methodological appraisal followed Strengthening the Reporting of Observational Studies in Epidemiology-Mendelian Randomization. Evidence was summarized by direction, variable category, quality, and consistency. An interactive MR-PCOS Atlas was developed using R Shiny. Of 728 records identified, 306 original MR studies were included, yielding 1081 extractable causal pathways (763 with PCOS as outcome, 318 as exposure).
Evidence concentrated in physiological traits and diseases/clinical phenotypes (312 and 299 pathways, respectively). Methodological quality was high in 13 studies, moderate in 279, and low in 14. Evidence most frequently addressed metabolic, endocrine, reproductive, and comorbidity pathways, while lifestyle, gut microbiota, immune phenotypes, and interventions remained limited. The MR-PCOS Atlas enables interactive browsing and comparison of published findings. This systematic synthesis provides a structured map of genetically supported PCOS associations and highlights areas of consistency, uncertainty, and methodological heterogeneity. Findings should be interpreted considering PCOS definitions, Genome-Wide Association Study sources, ancestry, and MR assumptions.
The MR-PCOS Atlas serves as an evidence resource for retrieval and hypothesis generation, not for direct clinical recommendations.
Authors’ abstract
Mendelian randomization (MR) studies have increasingly investigated potential predicted antecedents and consequences of polycystic ovary syndrome (PCOS), yet published evidence remains scattered across diverse exposures, outcomes, and analytical frameworks. This study aimed to systematically organize published PCOS-related MR evidence and develop an interactive platform to support evidence retrieval, comparison, and interpretation. We searched PubMed, Web of Science, Embase, and the Cochrane Library from inception to June 1, 2026. Original MR Studies were eligible if PCOS was either the exposure or the outcome, with extractable effect estimates.
Each causal pathway was extracted separately for direction, definitions, effect estimates, primary MR method, Genome-Wide Association Study sources, ancestry, sample size, PCOS phenotype, sensitivity analyses, and sample overlap. Methodological appraisal followed Strengthening the Reporting of Observational Studies in Epidemiology-Mendelian Randomization. Evidence was summarized by direction, variable category, quality, and consistency. An interactive MR-PCOS Atlas was developed using R Shiny. Of 728 records identified, 306 original MR studies were included, yielding 1081 extractable causal pathways (763 with PCOS as outcome, 318 as exposure).
Evidence concentrated in physiological traits and diseases/clinical phenotypes (312 and 299 pathways, respectively). Methodological quality was high in 13 studies, moderate in 279, and low in 14. Evidence most frequently addressed metabolic, endocrine, reproductive, and comorbidity pathways, while lifestyle, gut microbiota, immune phenotypes, and interventions remained limited. The MR-PCOS Atlas enables interactive browsing and comparison of published findings. This systematic synthesis provides a structured map of genetically supported PCOS associations and highlights areas of consistency, uncertainty, and methodological heterogeneity. Findings should be interpreted considering PCOS definitions, Genome-Wide Association Study sources, ancestry, and MR assumptions.
The MR-PCOS Atlas serves as an evidence resource for retrieval and hypothesis generation, not for direct clinical recommendations.
Publication and source details
Original title: Mapping the causal landscape of polycystic ovary syndrome
Sanwei Du; Dandan Dai; Wenhao Pan; Junlin Zhou; Kexin Wang
Medicine · 2026
* Correspondence: Dandan Dai, Department of Internal Medicine, The Shenzhen Clinical College, Guangzhou University of Chinese Medicine, Shenzhen 510006, China (e-mail: 1278494235@qq.com).Copyright © 2026 the Author(s). Published by Wolters Kluwer Health, LLC.2026https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-10T21:59:55.658669+00:00
DOI: 10.1097/md.0000000000050366 · PMC13502786